ER-positive breast cancer cells are poised for RET-mediated endocrine resistance

The RET tyrosine kinase signaling pathway is involved in the development of endocrine resistant ER+ breast cancer. However, we know little about how ER+ cells activate RET signaling and initiate an endocrine resistant phenotype. Here we show that both ER+ endocrine resistant and sensitive breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Horibata, Sachi, Rice, Edward J., Mukai, Chinatsu, Marks, Brooke A., Sams, Kelly, Zheng, Hui, Anguish, Lynne J., Coonrod, Scott A., Danko, Charles G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880349/
https://www.ncbi.nlm.nih.gov/pubmed/29608602
http://dx.doi.org/10.1371/journal.pone.0194023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880349/
https://www.ncbi.nlm.nih.gov/pubmed/29608602
http://dx.doi.org/10.1371/journal.pone.0194023

Ejemplares similares